78TiP Clinical evaluation of NVL-520, a highly selective ROS1 inhibitor in patients with advanced ROS1-positive solid tumors: The phase I/II ARROS-1 study
Title:
78TiP Clinical evaluation of NVL-520, a highly selective ROS1 inhibitor in patients with advanced ROS1-positive solid tumors: The phase I/II ARROS-1 study
Author:
Besse, B. Johnson, M. Ou, S-H.I. Gadgeel, S. Spira, A. Lin, J. Felip, E. van der Wekken, A.J. Calles, A. de Miguel, M.J. Camidge, D.R. Elamin, Y. Lopes, G.D.L. Liu, S. Bauman, J. Haggstrom, D. Riley, G. Pelish, H.E. Zhu, V.W. Drilon, A.